Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;188(4):e16.
doi: 10.1002/vetr.16. Epub 2021 Jan 16.

Owner compliance in canine epilepsy

Samantha Booth  1 , Sebastian Meller  2 , Rowena Ma Packer  1 , Robyn Farquhar  3 , Jill E Maddison  1 , Holger A Volk  1   2
Affiliations

Owner compliance in canine epilepsy

Samantha Booth et al. Vet Rec. 2021 Feb.

Abstract

Background: Poor medication compliance by human epilepsy patients is one of the leading causes of treatment failure and increased seizure frequency. The aim of this cross-sectional study was to analyse owner compliance in pharmacological treatment of canine idiopathic epilepsy and to identify factors associated with poor compliance.

Methods: The number of antiseizure drug tablets was recorded to determine if the patient received sufficient tablets to cover the time period between prescriptions and to assess compliant prescription cycles. Additionally, compliance was assessed by an online survey of owners.

Results: For the prescription monitoring data from 94 cases from three small animal practices in the United Kingdom revealed an overall median compliance of 56%. Thirt-three per cent of owners were >80% compliant, while 21% were 100% compliant. During a non-compliant prescription cycle, a patient missed a median of 6 days (0.11-519 days) of treatment. Patients on polytherapy had higher compliance rates than on monotherapy (p = 0.031). The survey (229 respondents from online canine epilepsy groups) showed that low daily dosing was associated with better compliance (p = 0.049).

Conclusion: Owner compliance was subpar in this study and could represent a significant issue in epilepsy management, which needs to be considered by veterinary surgeons when treating canine epilepsy.

PubMed Disclaimer

References

REFERENCES

    1. Charalambous M, Brodbelt D, Volk HA. Treatment in canine epilepsy - a systematic review. BMC Vet Res. 2014;10:257.
    1. Bhatti SFM, de Risio L, Muñana K, Penderis J, Stein VM, Tipold A, et al. International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe. BMC Vet Res. 2015;11:176.
    1. Charalambous M, Shivapour SK, Brodbelt DC, Volk HA. Antiepileptic drugs' tolerability and safety - a systematic review and meta‐analysis of adverse effects in dogs. BMC Vet Res. 2016;12:79.
    1. Podell M, Volk HA, Berendt M, Volk HA. 2015 ACVIM small animal consensus statement on seizure management in dogs. J Vet Intern Med. 2016;30:477–90.
    1. Boothe DM, Dewey C, Carpenter DM. Comparison of phenobarbital with bromide as a first‐choice antiepileptic drug for treatment of epilepsy in dogs. J Am Vet Med Assoc. 2012;240:1073–83.